{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T01:20:48Z","timestamp":1780536048533,"version":"3.54.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T00:00:00Z","timestamp":1595980800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T00:00:00Z","timestamp":1595980800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Division of Intramural Research, National Institute of Diabetes, and Digestive and Kidney Diseases","award":["Z99DK999999"],"award-info":[{"award-number":["Z99DK999999"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s00125-020-05236-y","type":"journal-article","created":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T11:03:52Z","timestamp":1596020632000},"page":"2194-2204","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Metformin improves blood glucose by increasing incretins independent of changes in gluconeogenesis in youth with type 2 diabetes"],"prefix":"10.1007","volume":"63","author":[{"given":"Celeste K. L.","family":"Cravalho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abby G.","family":"Meyers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilian S.","family":"Mabundo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber","family":"Courville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanna","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyi","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhai","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Walter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Walter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaji","family":"Chacko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran","family":"Cogen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheela N.","family":"Magge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morey W.","family":"Haymond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6989-0417","authenticated-orcid":false,"given":"Stephanie T.","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,29]]},"reference":[{"issue":"24","key":"5236_CR1","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1056\/NEJMoa1109333","volume":"366","author":"P Zeitler","year":"2012","unstructured":"Zeitler P, Hirst K, Pyle L et al (2012) A clinical trial to maintain glycemic control in youth with type 2 diabetes. N Engl J Med 366(24):2247\u20132256. https:\/\/doi.org\/10.1056\/NEJMoa1109333","journal-title":"N Engl J Med"},{"issue":"3","key":"5236_CR2","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s11892-007-0028-0","volume":"7","author":"H Yki-Jarvinen","year":"2007","unstructured":"Yki-Jarvinen H (2007) ADOPT: lessons from comparison of glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. Curr Diab Rep 7(3):173\u2013174. https:\/\/doi.org\/10.1007\/s11892-007-0028-0","journal-title":"Curr Diab Rep"},{"issue":"5","key":"5236_CR3","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.2337\/db10-1392","volume":"60","author":"SE Kahn","year":"2011","unstructured":"Kahn SE, Lachin JM, Zinman B et al (2011) Effects of rosiglitazone, glyburide, and metformin on beta-cell function and insulin sensitivity in ADOPT. Diabetes 60(5):1552\u20131560. https:\/\/doi.org\/10.2337\/db10-1392","journal-title":"Diabetes"},{"issue":"3","key":"5236_CR4","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1111\/pedi.12264","volume":"17","author":"MM Kelsey","year":"2016","unstructured":"Kelsey MM, Geffner ME, Guandalini C et al (2016) Presentation and effectiveness of early treatment of type 2 diabetes in youth: lessons from the TODAY study. Pediatr Diabetes 17(3):212\u2013221. https:\/\/doi.org\/10.1111\/pedi.12264","journal-title":"Pediatr Diabetes"},{"issue":"3","key":"5236_CR5","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.jpeds.2014.05.020","volume":"165","author":"N Walders-Abramson","year":"2014","unstructured":"Walders-Abramson N, Venditti EM, Ievers-Landis CE et al (2014) Relationships among stressful life events and physiological markers, treatment adherence, and psychosocial functioning among youth with type 2 diabetes. J Pediatr 165(3):504\u2013508.e501. https:\/\/doi.org\/10.1016\/j.jpeds.2014.05.020","journal-title":"J Pediatr"},{"issue":"3","key":"5236_CR6","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1007\/s00125-014-3455-x","volume":"58","author":"S Chung","year":"2015","unstructured":"Chung S, Hsia D, Chacko S, Rodriguez L, Haymond M (2015) Increased gluconeogenesis in youth with newly diagnosed type 2 diabetes. Diabetologia 58(3):596\u2013603. https:\/\/doi.org\/10.1007\/s00125-014-3455-x","journal-title":"Diabetologia"},{"key":"5236_CR7","doi-asserted-by":"publisher","unstructured":"Sekizkardes H, Chung ST, Chacko S et al (2020) Free fatty acid processing diverges in human pathologic insulin resistance conditions. J Clin Invest. https:\/\/doi.org\/10.1172\/jci135431","DOI":"10.1172\/jci135431"},{"issue":"11","key":"5236_CR8","doi-asserted-by":"publisher","first-page":"4059","DOI":"10.1210\/jcem.81.11.8923861","volume":"81","author":"K Cusi","year":"1996","unstructured":"Cusi K, Consoli A, DeFronzo RA (1996) Metabolic effects of metformin on glucose and lactate metabolism in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 81(11):4059\u20134067. https:\/\/doi.org\/10.1210\/jcem.81.11.8923861","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"5236_CR9","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/s41574-019-0242-2","volume":"15","author":"M Foretz","year":"2019","unstructured":"Foretz M, Guigas B, Viollet B (2019) Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus. Nat Rev Endocrinol 15(10):569\u2013589. https:\/\/doi.org\/10.1038\/s41574-019-0242-2","journal-title":"Nat Rev Endocrinol"},{"issue":"12","key":"5236_CR10","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.2337\/diabetes.49.12.2063","volume":"49","author":"RS Hundal","year":"2000","unstructured":"Hundal RS, Krssak M, Dufour S et al (2000) Mechanism by which metformin reduces glucose production in type 2 diabetes. Diabetes 49(12):2063\u20132069. https:\/\/doi.org\/10.2337\/diabetes.49.12.2063","journal-title":"Diabetes"},{"issue":"1","key":"5236_CR11","doi-asserted-by":"publisher","first-page":"24","DOI":"10.2337\/db07-0827","volume":"57","author":"R Basu","year":"2008","unstructured":"Basu R, Shah P, Basu A et al (2008) Comparison of the effects of pioglitazone and metformin on hepatic and extra-hepatic insulin action in people with type 2 diabetes. Diabetes 57(1):24\u201331. https:\/\/doi.org\/10.2337\/db07-0827","journal-title":"Diabetes"},{"issue":"9","key":"5236_CR12","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1056\/NEJM199508313330903","volume":"333","author":"M Stumvoll","year":"1995","unstructured":"Stumvoll M, Nurjhan N, Perriello G, Dailey G, Gerich JE (1995) Metabolic effects of metformin in non-insulin-dependent diabetes mellitus. N Engl J Med 333(9):550\u2013554. https:\/\/doi.org\/10.1056\/NEJM199508313330903","journal-title":"N Engl J Med"},{"issue":"4","key":"5236_CR13","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1097\/00060793-199811000-00003","volume":"5","author":"MP Christiansen","year":"1998","unstructured":"Christiansen MP, Hellerstein MK (1998) Effects of metformin on hepatic glucose metabolism. Curr Opin Endocrinol Diabetes Obes 5(4):252\u2013255","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"7","key":"5236_CR14","doi-asserted-by":"publisher","first-page":"2668","DOI":"10.1210\/jc.2018-02460","volume":"104","author":"EW Sun","year":"2019","unstructured":"Sun EW, Martin AM, Wattchow DA et al (2019) Metformin triggers PYY secretion in human gut mucosa. J Clin Endocrinol Metab 104(7):2668\u20132674. https:\/\/doi.org\/10.1210\/jc.2018-02460","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"5236_CR15","doi-asserted-by":"publisher","first-page":"e100778","DOI":"10.1371\/journal.pone.0100778","volume":"9","author":"A Napolitano","year":"2014","unstructured":"Napolitano A, Miller S, Nicholls AW et al (2014) Novel gut-based pharmacology of metformin in patients with type 2 diabetes mellitus. PLoS One 9(7):e100778. https:\/\/doi.org\/10.1371\/journal.pone.0100778","journal-title":"PLoS One"},{"issue":"23","key":"5236_CR16","doi-asserted-by":"publisher","first-page":"e93936","DOI":"10.1172\/jci.insight.93936","volume":"3","author":"E Bahne","year":"2018","unstructured":"Bahne E, Sun EWL, Young RL et al (2018) Metformin-induced glucagon-like peptide-1 secretion contributes to the actions of metformin in type 2 diabetes. JCI Insight 3(23):e93936. https:\/\/doi.org\/10.1172\/jci.insight.93936","journal-title":"JCI Insight"},{"issue":"6","key":"5236_CR17","first-page":"336","volume":"17","author":"E Mannucci","year":"2004","unstructured":"Mannucci E, Tesi F, Bardini G et al (2004) Effects of metformin on glucagon-like peptide-1 levels in obese patients with and without type 2 diabetes. Diabetes Nutr Metab 17(6):336\u2013342","journal-title":"Diabetes Nutr Metab"},{"issue":"Suppl 1","key":"5236_CR18","first-page":"1","volume":"42","author":"American Diabetes Association","year":"2019","unstructured":"American Diabetes Association (2019) Standards of care in diabetes. Diabetes Care 42(Suppl 1):1\u2013204","journal-title":"Diabetes Care"},{"issue":"2","key":"5236_CR19","doi-asserted-by":"publisher","first-page":"81","DOI":"10.2165\/11534750-000000000-00000","volume":"50","author":"GG Graham","year":"2011","unstructured":"Graham GG, Punt J, Arora M et al (2011) Clinical pharmacokinetics of metformin. Clin Pharmacokinet 50(2):81\u201398. https:\/\/doi.org\/10.2165\/11534750-000000000-00000","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"5236_CR20","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1093\/ajcn\/51.2.241","volume":"51","author":"MD Mifflin","year":"1990","unstructured":"Mifflin MD, St Jeor ST, Hill LA, Scott BJ, Daugherty SA, Koh YO (1990) A new predictive equation for resting energy expenditure in healthy individuals. Am J Clin Nutr 51(2):241\u2013247. https:\/\/doi.org\/10.1093\/ajcn\/51.2.241","journal-title":"Am J Clin Nutr"},{"issue":"4","key":"5236_CR21","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1152\/japplphysiol.00752.2007","volume":"104","author":"S Chacko","year":"2008","unstructured":"Chacko S, Sunehag A, Sharma S, Sauer PJJ, Haymond M (2008) Measurement of gluconeogenesis using glucose fragments and mass spectrometry after ingestion of deuterium oxide. J Appl Physiol 104(4):944\u2013951. https:\/\/doi.org\/10.1152\/japplphysiol.00752.2007","journal-title":"J Appl Physiol"},{"issue":"1","key":"5236_CR22","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1203\/00006450-200107000-00021","volume":"50","author":"AL Sunehag","year":"2001","unstructured":"Sunehag AL, Treuth MS, Toffolo G et al (2001) Glucose production, gluconeogenesis, and insulin sensitivity in children and adolescents: an evaluation of their reproducibility. Pediatr Res 50(1):115\u2013123. https:\/\/doi.org\/10.1203\/00006450-200107000-00021","journal-title":"Pediatr Res"},{"issue":"18","key":"5236_CR23","doi-asserted-by":"publisher","first-page":"e121495","DOI":"10.1172\/jci.insight.121495","volume":"3","author":"ST Chung","year":"2018","unstructured":"Chung ST, Courville AB, Onuzuruike AU et al (2018) Gluconeogenesis and risk for fasting hyperglycemia in black and white women. JCI Insight 3(18):e121495. https:\/\/doi.org\/10.1172\/jci.insight.121495","journal-title":"JCI Insight"},{"issue":"9","key":"5236_CR24","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","volume":"22","author":"M Matsuda","year":"1999","unstructured":"Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22(9):1462\u20131470. https:\/\/doi.org\/10.2337\/diacare.22.9.1462","journal-title":"Diabetes Care"},{"issue":"1","key":"5236_CR25","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1210\/jc.2004-1133","volume":"90","author":"E Ferrannini","year":"2005","unstructured":"Ferrannini E, Gastaldelli A, Miyazaki Y, Matsuda M, Mari A, DeFronzo RA (2005) \u03b2-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis. J Clin Endocrinol Metab 90(1):493\u2013500. https:\/\/doi.org\/10.1210\/jc.2004-1133","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"5236_CR26","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1111\/dom.13567","volume":"21","author":"MJ Borg","year":"2019","unstructured":"Borg MJ, Bound M, Grivell J et al (2019) Comparative effects of proximal and distal small intestinal administration of metformin on plasma glucose and glucagon-like peptide-1, and gastric emptying after oral glucose, in type 2 diabetes. Diabetes Obes Metab 21(3):640\u2013647. https:\/\/doi.org\/10.1111\/dom.13567","journal-title":"Diabetes Obes Metab"},{"issue":"3","key":"5236_CR27","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/dom.12826","volume":"19","author":"D Preiss","year":"2017","unstructured":"Preiss D, Dawed A, Welsh P et al (2017) Sustained influence of metformin therapy on circulating glucagon-like peptide-1 levels in individuals with and without type 2 diabetes. Diabetes Obes Metab 19(3):356\u2013363. https:\/\/doi.org\/10.1111\/dom.12826","journal-title":"Diabetes Obes Metab"},{"issue":"8","key":"5236_CR28","doi-asserted-by":"publisher","first-page":"e205","DOI":"10.1111\/j.1464-5491.2012.03675.x","volume":"29","author":"SK Thondam","year":"2012","unstructured":"Thondam SK, Cross A, Cuthbertson DJ, Wilding JP, Daousi C (2012) Effects of chronic treatment with metformin on dipeptidyl peptidase-4 activity, glucagon-like peptide 1 and ghrelin in obese patients with type 2 diabetes mellitus. Diabet Med 29(8):e205\u2013e210. https:\/\/doi.org\/10.1111\/j.1464-5491.2012.03675.x","journal-title":"Diabet Med"},{"issue":"7","key":"5236_CR29","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1038\/nm.4345","volume":"23","author":"H Wu","year":"2017","unstructured":"Wu H, Esteve E, Tremaroli V et al (2017) Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug. Nat Med 23(7):850\u2013858. https:\/\/doi.org\/10.1038\/nm.4345","journal-title":"Nat Med"},{"issue":"1","key":"5236_CR30","doi-asserted-by":"publisher","first-page":"54","DOI":"10.2337\/dc16-1324","volume":"40","author":"J de la Cuesta-Zuluaga","year":"2017","unstructured":"de la Cuesta-Zuluaga J, Mueller NT, Corrales-Agudelo V et al (2017) Metformin is associated with higher relative abundance of mucin-degrading Akkermansia muciniphila and several short-chain fatty acid-producing microbiota in the gut. Diabetes Care 40(1):54\u201362. https:\/\/doi.org\/10.2337\/dc16-1324","journal-title":"Diabetes Care"},{"issue":"7","key":"5236_CR31","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1056\/NEJMoa1903822","volume":"381","author":"WV Tamborlane","year":"2019","unstructured":"Tamborlane WV, Barrientos-Perez M, Fainberg U et al (2019) Liraglutide in children and adolescents with type 2 diabetes. N Engl J Med 381(7):637\u2013646. https:\/\/doi.org\/10.1056\/NEJMoa1903822","journal-title":"N Engl J Med"},{"issue":"3","key":"5236_CR32","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1042\/BJ20140620","volume":"462","author":"HR Bridges","year":"2014","unstructured":"Bridges HR, Jones AJ, Pollak MN, Hirst J (2014) Effects of metformin and other biguanides on oxidative phosphorylation in mitochondria. Biochem J 462(3):475\u2013487. https:\/\/doi.org\/10.1042\/BJ20140620","journal-title":"Biochem J"},{"issue":"7506","key":"5236_CR33","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/nature13270","volume":"510","author":"AK Madiraju","year":"2014","unstructured":"Madiraju AK, Erion DM, Rahimi Y et al (2014) Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase. Nature 510(7506):542\u2013546. https:\/\/doi.org\/10.1038\/nature13270","journal-title":"Nature"},{"issue":"12","key":"5236_CR34","doi-asserted-by":"publisher","first-page":"3996","DOI":"10.2337\/db15-0640","volume":"64","author":"ST Chung","year":"2015","unstructured":"Chung ST, Chacko SK, Sunehag AL, Haymond MW (2015) Measurements of gluconeogenesis and glycogenolysis: a methodological review. Diabetes 64(12):3996\u20134010. https:\/\/doi.org\/10.2337\/db15-0640","journal-title":"Diabetes"},{"issue":"4","key":"5236_CR35","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s40262-015-0323-x","volume":"55","author":"F Kajbaf","year":"2016","unstructured":"Kajbaf F, De Broe ME, Lalau JD (2016) Therapeutic concentrations of metformin: a systematic review. Clin Pharmacokinet 55(4):439\u2013459. https:\/\/doi.org\/10.1007\/s40262-015-0323-x","journal-title":"Clin Pharmacokinet"},{"issue":"5","key":"5236_CR36","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/clpt.2011.165","volume":"90","author":"JH Choi","year":"2011","unstructured":"Choi JH, Yee SW, Ramirez AH et al (2011) A common 5\u2032-UTR variant in MATE2-K is associated with poor response to metformin. Clin Pharmacol Ther 90(5):674\u2013684. https:\/\/doi.org\/10.1038\/clpt.2011.165","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"5236_CR37","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/clpt.2012.210","volume":"93","author":"SL Stocker","year":"2013","unstructured":"Stocker SL, Morrissey KM, Yee SW et al (2013) The effect of novel promoter variants in MATE1 and MATE2 on the pharmacokinetics and pharmacodynamics of metformin. Clin Pharmacol Ther 93(2):186\u2013194. https:\/\/doi.org\/10.1038\/clpt.2012.210","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"5236_CR38","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/tpj.2009.15","volume":"9","author":"ML Becker","year":"2009","unstructured":"Becker ML, Visser LE, van Schaik RH, Hofman A, Uitterlinden AG, Stricker BH (2009) Genetic variation in the organic cation transporter 1 is associated with metformin response in patients with diabetes mellitus. Pharmacogenomics J 9(4):242\u2013247. https:\/\/doi.org\/10.1038\/tpj.2009.15","journal-title":"Pharmacogenomics J"},{"issue":"9","key":"5236_CR39","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1007\/s00125-017-4335-y","volume":"60","author":"JC Florez","year":"2017","unstructured":"Florez JC (2017) The pharmacogenetics of metformin. Diabetologia 60(9):1648\u20131655. https:\/\/doi.org\/10.1007\/s00125-017-4335-y","journal-title":"Diabetologia"},{"issue":"6","key":"5236_CR40","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s11892-018-0997-1","volume":"18","author":"ET Jensen","year":"2018","unstructured":"Jensen ET, Dabelea D (2018) Type 2 diabetes in youth: new lessons from the SEARCH study. Curr Diab Rep 18(6):36. https:\/\/doi.org\/10.1007\/s11892-018-0997-1","journal-title":"Curr Diab Rep"},{"key":"5236_CR41","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/978-3-319-70178-3_4","volume":"1043","author":"A Basu","year":"2017","unstructured":"Basu A, Dube S, Basu R (2017) Men ARE from Mars, women are from Venus: sex differences in insulin action and secretion. Adv Exp Med Biol 1043:53\u201364. https:\/\/doi.org\/10.1007\/978-3-319-70178-3_4","journal-title":"Adv Exp Med Biol"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-020-05236-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00125-020-05236-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-020-05236-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T00:02:44Z","timestamp":1627516964000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00125-020-05236-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,29]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["5236"],"URL":"https:\/\/doi.org\/10.1007\/s00125-020-05236-y","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,29]]},"assertion":[{"value":"7 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}